Impact Evaluation of the Use of Community Volunteers and Patent Medicine Vendors for Malaria Control in Anambra State and Gombe State 2014 -2015, Endline Survey
Nigeria, 2014 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
109785
Downloads
679
BRAND NAME, INCLUDING DRUG SPECIFICATIONS (brandname_drug8)
Data file: pmv_release
Overview
Valid:
20
Invalid:
0
Type:
Discrete
Start:
5634
End:
5677
Width:
44
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 2-2-1 forte capsules | 1 |
5%
|
|
| 2-2-1. Chloroquine sulphate | 1 |
5%
|
|
| Amalar ( sp ) | 1 |
5%
|
|
| Artesunat ( Artesunate ) | 2 |
10%
|
|
| Artesunate amodiaquine | 1 |
5%
|
|
| Grutha fort (Artemether and Lumefantrine ) | 1 |
5%
|
|
| LYNSUNATE FORTE | 1 |
5%
|
|
| Laridox ( sp ) | 1 |
5%
|
|
| Lonart ACT | 1 |
5%
|
|
| Lonart-DS ( Artemether and Lumefantrine ) | 2 |
10%
|
|
| Lumartem (Act ) | 1 |
5%
|
|
| Malareich | 1 |
5%
|
|
| Maxiquine | 1 |
5%
|
|
| P-Alaxin ( Dihydroartemisin and piperaquine) | 1 |
5%
|
|
| P-alaxin | 1 |
5%
|
|
| Rohamal | 1 |
5%
|
|
| Waipa ( Act ) | 1 |
5%
|
|
| Waipa ACT | 1 |
5%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.